Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort

European Urology
Gunnar AusE Varenhorst

Abstract

At presentation of prostate cancer, patients with proven lymph node metastasis (N1) are comparatively rare. It is difficult to give prognostic information based on the present literature. The aim of this study was to evaluate the impact of known risk factors in patients with pelvic node involvement and without distant metastasis. From the population-based, prospective prostate cancer tumour registry of the South-East Region in Sweden, we collected data on all 181 patients with N1, M0 prostate cancer diagnosed from January 1987 to October 2000 with a follow-up to December 2001. Mean follow-up was 62 months. Pre-operative risk factors as age, T-category, serum PSA, tumour grade and also primary treatment given was correlated to the outcome. Median age at diagnosis was 65 years. Cancer-specific survival was highly variable with 5-year survival of 72%, a median of 8 years and the projected 13-year figure was 31%. T-category, age, PSA or treatment did not affect the outcome while poorly differentiated tumours had a tendency towards lower cancer-specific survival (p=0.0523) when compared to well and moderately differentiated tumours. This population-based cohort of prostate cancer patients with pelvic node involvement treated princip...Continue Reading

References

Jan 1, 1995·International Journal of Radiation Oncology, Biology, Physics·M E SandsG K Zagars
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Theodore J RobnettAlan J Wein

❮ Previous
Next ❯

Citations

Sep 17, 2010·Der Urologe. Ausg. A·A Heidenreich, A J Schrader
May 24, 2007·Prostate Cancer and Prostatic Diseases·G P SwansonM Herman
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn L PenneyLorelei A Mucci
May 11, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Alexander WinterFriedhelm Wawroschek
Feb 10, 2004·The Journal of Urology·Ulrike ZwergelMichael Stoeckle
Sep 6, 2006·The Journal of Urology·Gregory SwansonE David Crawford
Aug 16, 2016·Der Urologe. Ausg. A·M J Nothacker
Jan 11, 2005·BJU International·Vijay K SangarRosie A Blades
Jan 20, 2017·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Filip PoelaertNicolaas Lumen
Dec 1, 2006·Expert Review of Anticancer Therapy·Tanya B DorffJacek Pinski
Feb 14, 2006·Nature Clinical Practice. Urology·Fiona C BurkhardUrs E Studer
May 16, 2006·Cancer·Gregory P SwansonJoseph Basler
Oct 16, 2007·Scandinavian Journal of Urology and Nephrology·Jan AdolfssonPär Stattin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.